Anti-TFPI Antibody (Befovacimab)
Catalog No.
F1466
Anti-TFPI Antibody (Befovacimab)
Featured Products
Befovacimab (BAY 1093884) is a fully human monoclonal IgG2 antibody that binds tissue factor pathway inhibitor (TFPI). Befovacimab is indicated for use in hemophilia A/B research.
Quality Control & DataSheet
- View current batch:
-
Purity > 90% by SDS-PAGE and SEC-HPLC analyses.
- MSDS (Material Safety Data Sheet)
- Datasheet
143.24 kDa
Dry ice
2156634-62-5
-80°C
2 years
Liquid
See label
For reconstitution, we recommend adding sterile, distilled water to achieve a final antibody concentration. Gently shake it to solubilize the protein completely. Do not vortex.
CHO
BAY1093884
100 mM Pro 20 mM Arg pH 5.0. No preservative!
P10646
Human
Unconjugated
Monoclonal
Protein A
IgG2SA
ELISA, FACS, Kinetics, Functional assay, Animal Model
TFPI
Please avoid freeze-thaw cycles.